RxAnte, Inc.

Amendment
CIK: 0001556197·Other Health Care·DELAWARE·Filed: May 16, 2022
Total Offering

$10,900,000

Amount Sold

$10,900,000

Investors

7

First Sale

Oct 8, 2020

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Eileen Casal
Related Person
Brenton Burns
Related Person
Chronis Manolis
Related Person
Nicholas Shapiro
Related Person
Loren Lidsky
Related Person
Jonathan Phillips
Related Person
Joshua Benner
Related Person
Mohit Kaushal
Related Person
Corbin Director
Related Person
Greg Lahens
Related Person
Marc Wise
Related Person

Company

RxAnte, Inc.

511 CONGRESS STREET

PORTLAND, ME, 04101

703-300-5459

SEC Filing

0001556197-22-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free